Loading...
XAMS
CRBN
Market cap1.11bUSD
Apr 09, Last price  
17.39EUR
1D
-1.92%
1Q
-18.43%
Jan 2017
-31.62%
Name

Corbion NV

Chart & Performance

D1W1MN
No data to show
P/E
5.26
P/S
0.78
EPS
3.31
Div Yield, %
7.59%
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
5.70%
Revenues
1.29b
-10.78%
2,391,600,0002,421,400,0002,485,600,0002,599,300,0002,555,900,0002,990,100,0003,112,600,000753,700,000743,600,000770,100,000918,300,000911,300,000891,700,000897,200,000976,400,000986,500,0001,070,800,0001,457,900,0001,443,800,0001,288,100,000
Net income
192m
+163.65%
423,400,000104,700,000202,800,00090,000,00086,800,00099,300,000-174,300,000-63,700,0002,400,000-20,700,00080,200,000103,600,00084,600,00054,300,00025,800,00073,100,00078,300,00090,000,00072,900,000192,200,000
CFO
184m
+11.31%
833,000,000177,800,000138,800,00098,500,000277,200,000188,600,000148,000,000197,400,0009,900,00066,800,000110,300,000122,600,000117,700,00099,500,000115,700,000113,400,00026,700,00053,200,000165,400,000184,100,000
Dividend
May 16, 20250 EUR/sh

Profile

Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. The company offers ingredient solutions made from renewable resources for the food, home and personal care, pharmaceutical, animal nutrition, medical device, and bioplastics markets. It markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.
URL
http://www.corbion.com/
IPO date
Jan 04, 1999
Employees
2,601
Domiciled in
NL
Incorporated in
NL

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,288,100
-10.78%
1,443,800
-0.97%
1,457,900
36.15%
Cost of revenue
1,211,600
1,321,400
1,352,000
Unusual Expense (Income)
NOPBT
76,500
122,400
105,900
NOPBT Margin
5.94%
8.48%
7.26%
Operating Taxes
16,600
12,400
26,400
Tax Rate
21.70%
10.13%
24.93%
NOPAT
59,900
110,000
79,500
Net income
192,200
163.65%
72,900
-19.00%
90,000
14.94%
Dividends
(41,900)
(33,100)
(33,000)
Dividend yield
3.27%
2.86%
1.74%
Proceeds from repurchase of equity
(20,000)
BB yield
1.56%
Debt
Debt current
201,300
368,500
322,000
Long-term debt
366,900
481,900
437,200
Deferred revenue
12,900
61,200
Other long-term liabilities
11,300
29,900
19,800
Net debt
518,900
695,500
606,400
Cash flow
Cash from operating activities
184,100
165,400
53,200
CAPEX
(84,200)
(149,300)
(235,800)
Cash from investing activities
166,000
(146,800)
(213,300)
Cash from financing activities
(371,700)
(5,300)
173,900
FCF
152,500
128,700
(271,000)
Balance
Cash
49,300
70,200
58,200
Long term investments
84,700
94,600
Excess cash
82,710
79,905
Stockholders' equity
690,600
555,400
570,500
Invested Capital
1,293,000
1,368,890
1,322,695
ROIC
4.50%
8.17%
6.86%
ROCE
5.84%
8.27%
7.30%
EV
Common stock shares outstanding
59,321
59,700
59,500
Price
21.60
11.46%
19.38
-39.13%
31.84
-23.17%
Market cap
1,281,333
10.75%
1,156,986
-38.93%
1,894,480
-23.04%
EV
1,800,233
1,852,486
2,500,880
EBITDA
163,300
207,000
178,600
EV/EBITDA
11.02
8.95
14.00
Interest
22,700
29,700
17,400
Interest/NOPBT
29.67%
24.26%
16.43%